GEN videos are informative, entertaining, and encompass all aspects of biotechnology.
Dr. James Wilson is a professor in the department of pathology and laboratory medicine, and the director of the gene therapy program, at the University of Pennsylvania. He is also the editor of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. During this interview with GEN, Dr. Wilson discusses his thoughts on whether recent developments in cell and gene therapy represent just another biotech bubble, or illustrate significant advances in the field.
In addition to this SKYPE interview, Dr. Wilson further elaborated on his view of the current status of cell and gene therapy in a column in the August 2013 issue of Human Gene Therapy which you can access by clicking here.
Will Gene Therapy Cure Cancer?
Jonathan Strickland walks through the process of human gene therapy, reveals it's exciting potential, and questions the ethics of genetic modification and altering DNA.
Synthetic Biology Explained
From selective breeding to genetic modification, our understanding of biology is now merging with the principles of engineering to bring us synthetic biology.
Nanobiotechnology: Putting Molecular Machines to Work
Describes the concepts of high-throughput protein expression coupled with immobilizations in functionalized nanoporous materials to carry out multiple kinds of diverse reactions.
Year in Review: Advances in Stem Cell Research
2014 was a year of high-profile advances and one big scandal in the field of stem cell science, the Wall Street Journal's Gautam Naik reports.
Crash Course: DNA Structure and Replication
An introduction to molecule deoxyribonucleic acid—also known as DNA—and an explanation of how it replicates itself in our cells.
Careers in Biotechnology
Explore various careers in biotechnology, with perspectives offered by Pfizer employees.
Blood-Cleansing Biospleen Developed
Researchers at Harvard's Wyss Institute discover a new breakthrough in the battle against pathogens—nano magnets that can clean the blood.
Ebola: Prevention and Containment
Diagnostics analyst Aish Vivekanadan with Frost & Sullivan's global Life Sciences practices sheds light on why Ebola is so hard to treat, currently available diagnostic tests, companies pursuing other tests and the roadblocks in the way of progress.
GEN Touch: Stay in the Know Wherever You Go
Introducing GEN Touch, a new app lets you keep up with the latest biotech news and insights on your smart phone or tablet. We've designed versions for quick and easy reading on Apple and Android devices.
Andrew Jenner's Take on The Value of Innovation
In this video, Andrew Jenner, the International Federation of Pharmaceutical Manufacturers & Associations' executive director, corporate strategy & legal affairs, gives the pharmaceutical industry perspective on innovation. Despite the growing scientific, IP, and regulatory challenges of the past decades, over 340 new drugs have been introduced since 2002 to treat different chronic and nonchronic diseases. This can be considered as a big success story. Watch the video to find out why.